DRTS

Conviction 80HealthcareScan · Thu, Sep 24, 2026

Alpha Tau Medical Ltd. (DRTS) closed at $14.76 (+1.65%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 53, RS Rating 98, -4.8% from its 52-week high, +205.6% year to date. Sector: Healthcare · Biotechnology.

DRTS$14.76+1.65%

ResistanceSupportVol 14Insider sell

Vol MA14 532.23K

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

WSB mentions · 24h changelatest +400.00%· 5 mentions

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Alpha Tau Medical Ltd.Biotechnologywww.alphatau.com ↗

Price14.76

Change+1.65%

Gap+0.14%

Rel volume0.62×

Avg volume649.53K

Avg $ vol9.51M

SMA 2014.72

SMA 5013.91

SMA 2009.50

Price vs 50+6.12%

Price vs 200+55.35%

MA stackbullish

50/200 cross—

Supertrendup · 13.39

RSI (14)53

MACD hist-0.06

MACD crossbear · 1d

Stoch %K / %D48 / 51

ADX (14)16

+DI / −DI17 / 18

RSI divergence—

MACD divergence—

ATR %4.46%

ADR %4.49%

52w high15.50

52w low3.47

From 52w high-4.77%

Above 52w low+325.36%

New 52w highNo

SqueezeOn · 15d

Bollinger width11.40%

%B0.52

Donchian pos51.87%

Donchian high15.79

Donchian low13.65

AVWAP (52w high)15.13

vs AVWAP high-2.44%

AVWAP (52w low)10.25

vs AVWAP low+43.94%

OBV trendDown

Chaikin MF (20)-0.19

Today vs 20d0.62×

Avg vol (14d)532.23K

Avg vol (20d)649.53K

Avg $ vol (20d)9.51M

Market cap1.3B

RS Rating98 / 99

RS 3m (vs SPY)+27.65%

RS 6m (vs SPY)+92.25%

RS line new highNo

Trend template8/8

Technical rank85.6

1 week-4.71%

1 month+0.41%

3 months+32.14%

6 months+109.07%

1 year+258.25%

YTD+205.59%

P/E—

P/B16.85

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq0.00

Current7.45

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target18.00

Target upside21.95%

Analyst ratingBuy

Institutional8.61%

Ent. value1.29B

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out90.33M

Employees121

ListedTue, Mar 8, 2022

Free float46.86M

Float %53.2%

Short interest3.09M

Days to cover4.3d

Short volume38.4%

Squeeze score35 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.50 vs −$0.14

Last surprise-257.1% miss

Setup gradeA

Conviction80 / 100

Pattern quality—

Tech rank85.6 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance15.48

Support13.74

Days since event—

Candle confirm—

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Setting up
Jul 17 – Sep 16
6 scans
→
Breaking out now
Sep 17
1 scan

Congress activity

Disclosed STOCK Act trades in DRTS

All disclosures →

No recent disclosed trades by Congress in DRTS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DRTS · open-market 6 sells

Insider	Side	Shares	Value	Traded	Filed
Levy Raphi Chief Financial Officer · Ordinary Shares · 2026-08-21	Exercise	2.87K	$9K	2026-08-21	2026-08-25
Levy Raphi Chief Financial Officer · Ordinary Shares · 2026-08-21	Sell	2.87K	$43K	2026-08-21	2026-08-25
Levy Raphi Chief Financial Officer · Ordinary Shares · 2026-08-11	Exercise	17.73K	$53K	2026-08-11	2026-08-12
Levy Raphi Chief Financial Officer · Ordinary Shares · 2026-08-11	Sell	17.73K	$248K	2026-08-11	2026-08-12
Levy Raphi Chief Financial Officer · Ordinary Shares · 2026-07-06	Exercise	2.27K	$7K	2026-07-06	2026-07-07
Levy Raphi Chief Financial Officer · Ordinary Shares · 2026-07-06	Sell	2.27K	$32K	2026-07-06	2026-07-07
Levy Raphi Chief Financial Officer · Ordinary Shares · 2026-07-02	Exercise	17.87K	$53K	2026-07-02	2026-07-06
Levy Raphi Chief Financial Officer · Ordinary Shares · 2026-07-02	Sell	17.87K	$232K	2026-07-02	2026-07-06
Levy Raphi Chief Financial Officer · Ordinary Shares · 2026-06-25	Sell	4.22K	$46K	2026-06-25	2026-06-26
Levy Raphi Chief Financial Officer · Ordinary Shares · 2026-06-25	Sell	15.78K	$174K	2026-06-25	2026-06-26

SEC filings

EDGAR filings in DRTS · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.